97 related articles for article (PubMed ID: 11820857)
21. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
[TBL] [Abstract][Full Text] [Related]
22. Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo.
Al-Khaldi A; Eliopoulos N; Martineau D; Lejeune L; Lachapelle K; Galipeau J
Gene Ther; 2003 Apr; 10(8):621-9. PubMed ID: 12692590
[TBL] [Abstract][Full Text] [Related]
23. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo.
Ramakrishnan S; Olson TA; Bautch VL; Mohanraj D
Cancer Res; 1996 Mar; 56(6):1324-30. PubMed ID: 8640821
[TBL] [Abstract][Full Text] [Related]
25. Fibrin-based biomaterials to deliver human growth factors.
Wong C; Inman E; Spaethe R; Helgerson S
Thromb Haemost; 2003 Mar; 89(3):573-82. PubMed ID: 12624643
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
[TBL] [Abstract][Full Text] [Related]
28. The coronary endothelium: a target for vascular endothelial growth factor. Human coronary artery endothelial cells express functional receptors for vascular endothelial growth factor in vitro and in vivo.
Kranz A; Mayr U; Frank H; Waltenberger J
Lab Invest; 1999 Aug; 79(8):985-91. PubMed ID: 10462036
[TBL] [Abstract][Full Text] [Related]
29. Endometrial endothelial cells express estrogen and progesterone receptors and exhibit a tissue specific response to angiogenic growth factors.
Iruela-Arispe ML; Rodriguez-Manzaneque JC; Abu-Jawdeh G
Microcirculation; 1999 Jun; 6(2):127-40. PubMed ID: 10466115
[TBL] [Abstract][Full Text] [Related]
30. Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism.
Armstrong LC; Björkblom B; Hankenson KD; Siadak AW; Stiles CE; Bornstein P
Mol Biol Cell; 2002 Jun; 13(6):1893-905. PubMed ID: 12058057
[TBL] [Abstract][Full Text] [Related]
31. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
32. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
[TBL] [Abstract][Full Text] [Related]
33. Mitogenic G(i) protein-MAP kinase signaling cascade in MC3T3-E1 osteogenic cells: activation by C-terminal pentapeptide of osteogenic growth peptide [OGP(10-14)] and attenuation of activation by cAMP.
Gabarin N; Gavish H; Muhlrad A; Chen YC; Namdar-Attar M; Nissenson RA; Chorev M; Bab I
J Cell Biochem; 2001; 81(4):594-603. PubMed ID: 11329614
[TBL] [Abstract][Full Text] [Related]
34. Eicosapentaenoic acid attenuates vascular endothelial growth factor-induced proliferation via inhibiting Flk-1 receptor expression in bovine carotid artery endothelial cells.
Yang SP; Morita I; Murota SI
J Cell Physiol; 1998 Aug; 176(2):342-9. PubMed ID: 9648921
[TBL] [Abstract][Full Text] [Related]
35. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies.
Kim KJ; Li B; Houck K; Winer J; Ferrara N
Growth Factors; 1992; 7(1):53-64. PubMed ID: 1380254
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro.
Lamoreaux WJ; Fitzgerald ME; Reiner A; Hasty KA; Charles ST
Microvasc Res; 1998 Jan; 55(1):29-42. PubMed ID: 9473407
[TBL] [Abstract][Full Text] [Related]
37. Osteogenic growth peptide increases blood and bone marrow cellularity and enhances engraftment of bone marrow transplants in mice.
Gurevitch O; Slavin S; Muhlrad A; Shteyer A; Gazit D; Chorev M; Vidson M; Namdar-Attar M; Berger E; Bleiberg I; Bab I
Blood; 1996 Dec; 88(12):4719-24. PubMed ID: 8977266
[TBL] [Abstract][Full Text] [Related]
38. Mitogenic action of osteogenic growth peptide (OGP): role of amino and carboxy-terminal regions and charge.
Greenberg Z; Chorev M; Muhlrad A; Shteyer A; Namdar M; Mansur N; Bab I
Biochim Biophys Acta; 1993 Sep; 1178(3):273-80. PubMed ID: 8364043
[TBL] [Abstract][Full Text] [Related]
39. Structure-bioactivity of C-terminal pentapeptide of osteogenic growth peptide [OGP(10-14)].
Chen YC; Bab I; Mansur N; Muhlrad A; Shteyer A; Namdar-Attar M; Gavish H; Vidson M; Chorev M
J Pept Res; 2000 Sep; 56(3):147-56. PubMed ID: 11007271
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo.
Jin K; Zhu Y; Sun Y; Mao XO; Xie L; Greenberg DA
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11946-50. PubMed ID: 12181492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
